Posts by: Michael Nace

Michael Nace

Michael Nace serves as the Editor-in-Chief of Multiple Sclerosis News Today.

December 3, 2015

Coral Gables, FL MS Exchange Event This Saturday To Explore Relapsing MS Management

An interactive event in Coral Gables, FL this weekend will give relapsing Multiple Sclerosis patients who live in the area access to best practices and therapeutic ... Read more

October 10, 2015October 10, 2015

Mike Nace, Editor-in-Chief of Multiple Sclerosis News Today, Reviews Day 2-3 at #ECTRIMS2015

News

Read the articles mentioned in the podcast: #ECTRIMS2015 – Another Attendee Record #ECTRIMS2015 – “Vitamin D plays important role in MS inflammation.” – Jorge Correale #ECTRIMS2015 – ... Read more

June 16, 2015June 16, 2015

FDA Taps Online Patient Database To Gain Access To Patient-Reported MS Health Data

Multiple Sclerosis News, News

In an effort to access firsthand patient data as a means of improving healthcare and drug safety, the Food and Drug Administration (FDA) has announced a unique ... Read more

October 15, 2014

Spasticity Drug to be Tested on Multiple Sclerosis Patients in Early 2015

Multiple Sclerosis News, News

Concert Pharmaceuticals, Inc. will announce their latest results from the Phase 1 data of CTP-354, a drug developed to treat spasticity — a chronic condition associated ... Read more

August 11, 2014September 10, 2017

Higher Body Temperature in RRMS Patients Could Cause Increased Fatigue

Multiple Sclerosis News, News

Researchers have recently discovered that the fatigue that patients with multiple sclerosis (MS) experience is not the same kind of fatigue that healthy people feel from time to ... Read more

August 10, 2014October 21, 2015

JCV Virus May Be Missed in Patients Who Take Popular MS Drug, According To Study

Multiple Sclerosis News, News

Multiple sclerosis (MS) patients who are prescribed Tysabri have an increased risk to develop the rare, often fatal infection of the brain called progressive multifocal leukoencephalopathy (PML), according to ... Read more

May 30, 2014

MS Views & News Awards Questcor With “Recognition of Appreciation” Award Multiple Sclerosis Advocacy

Multiple Sclerosis News, News

Questcor Pharmaceuticals, Inc. is a drug development company with a viable Multiple Sclerosis drug called H.P. Acthar® Gel, which is currently approved in the U.S. by ... Read more

May 2, 2014

New Multiple Sclerosis Drug Target of U.S. and Japanese Researchers

Multiple Sclerosis News

The National Center of Neurology and Psychiatry, based in Japan, announced that they will initiate a 3-month clinical trial on 9 patients with multiple sclerosis, beginning in March. Multiple sclerosis is an ... Read more

May 2, 2014May 2, 2014

Benefits of Cognitive Reserve in Multiple Sclerosis May Also Benefit TBI Patients

News

Researchers from the Kessler Foundation have found that higher educational achievement reduces the negative impact of traumatic brain injury (TBI) on cognitive status. The study appeared in Archives of Physical Medicine ... Read more

Pin It on Pinterest